Hans Kemming, longarts, UMC Utrecht
De opleiding tot longarts werd tussen 2008 en 2014 hoofdzakelijk gevolgd in het Rijnstate Ziekenhuis Arnhem en daarnaast tijdelijk in het Radboud Ziekenhuis te Nijmegen (externe stage TBC).
Sinds 2014 is hij werkzaam binnen het UMC Utrecht. Allereerst tot 2017 bij het CTB binnen de divisie interne geneeskunde. Vanaf 2017 is hij werkzaam binnen de afdeling longziekten.
🎤 Presentation: A multidisciplinary approach to stem cell therapy for airway fistulas – closing the (program) gap
Airway fistulas are aberrant connections between airway and other organs/body compartments which mainly arise after surgical procedures like esophagectomy for esophageal carcinoma (broncho-esophageal fistula) or pneumonectomy for lungcancer (bronchopleural fistula).
In the case of a fistula between airway and upper digestive tract, patients suffer from aspiration, airway infections and are frequently dependent on tube feeding. Options to treat those fistulas are surgical procedures and more conservative treatments like stenting and clipping techniques.
Another less invasive treatment is the use of different kind of stem cells (embryonic, mesenchymal or adipose tissue-derived).
From the literature, mainly case reports/series, there is growing evidence that these procedures are hopeful, noninvasive alternatives to surgical procedures.
In our hospital (University Medical Center Utrecht) we have started to inject adipose tissue-derived stromal stem cells (ASC’s) for the treatment of broncho-esophageal fistulas (BEF) in a multidisciplinary approach. In this presentation I’ll show you some backgrounds, our experiences, results and possible applications for the future.
Â
- Vrijdag 16 januari
A multidisciplinary approach to stem cell therapy for airway fistulas
Datum: 16 jan 2026Tijd: 14:15 - 14:40